5y outlook: Home health occupational therapy demand is likely to remain stable due to aging populations and home-based care expansion, but this part-time role will likely be paid hourly or per visit and prorated from the posted full-time salary range.
Job intelligence board
Loading scored roles…
Side-income and flexible healthcare opportunities
Part-time, freelance, contract, PRN/per-diem, locum, paid research, expert-call, and project-based opportunities for clinicians exploring income beyond traditional full-time clinical work.
5y outlook: Likely structured as base salary plus variable incentive tied to retention and growth; earnings can increase with PBM/account management experience, but exact compensation depends on portfolio, quota, and geography. This is not an entry-level non-clinical transition role.
Optum/UHG
5y outlook: The posting lists an hourly range of $44-$79, but per diem hours may be irregular and benefits eligibility can vary. Long-term earnings depend on coverage volume, location needs, and progression into full-time or specialized pharmacy roles.
5y outlook: Likely a stable senior individual-contributor accounting path within a large healthcare organization. Compensation is not disclosed and will depend on market, credentials, and PBM/healthcare finance experience.
Monash University
5y outlook: Advertised at HEW10A (roughly A$191k), this sits at the top of the university professional staff band, so further upside is limited within the same level and typically requires moving into executive/director portfolios. Growth depends heavily on university-industry funding cycles and research commercialisation budgets rather than clinical demand.
5y outlook: Advertised AHP1/AHP2 public-sector salary range with regional/locality allowances and salary packaging; progression depends on SA Health bands, experience and specialisation.
5y outlook: Public-sector aged care nursing leadership roles typically offer stable salary progression through nursing leadership/management bands, with modest increases tied to seniority, location and public-sector agreements.
Cardinal Health
5y outlook: Pricing and account management skills in pharmaceutical distribution tend to remain steady in demand, with advancement toward senior pricing, contract, or account management roles. Compensation will vary by market, experience, and company, so exact figures should be verified against local benchmarks.
Instinct
5y outlook: Likely a competitive health-tech customer success/implementation role with progression toward senior onboarding, implementation leadership, or customer success management. Compensation will vary by geography, experience, and SaaS company size; no salary figure is stated in the posting.
5y outlook: Senior field clinical research roles in medtech generally offer competitive compensation and can grow into clinical operations, site management, or program leadership. Exact salary depends on territory, experience, and total rewards package.
General Dynamics Information Technology
5y outlook: The posting lists a relatively strong hourly range, but the role is only 8 hours per week and tied to a specific DHA contract, so annual income and long-term growth are limited unless it expands into broader research program management.
5y outlook: This is a senior executive compensation band with bonus and long-term incentives; future outlook is tied to clinical development outsourcing and site contracting leadership demand.
Lifelancer
5y outlook: Mid-level CRO regulatory and study start-up roles in Canada typically offer stable compensation with progression toward regulatory lead, start-up lead, or clinical operations management. Exact pay is not stated and will depend on CRO, location, and prior Health Canada submission experience.
5y outlook: Commission-only medical device sales can produce strong earnings for high performers, but income is variable and territory-dependent. The lack of a stated base salary creates meaningful financial risk during the transition.
Parexel
5y outlook: Likely mid-to-senior CRO compensation with benefits, with growth potential toward clinical operations, feasibility management, or site engagement leadership. Exact salary varies by EMEA country, CRO, and prior clinical research experience.
5y outlook: Senior CRO business development compensation is likely tied to contract wins and account performance, with meaningful upside for candidates who already have pharma/biotech relationships. It is not an entry-level commercial transition role.
5y outlook: The posting cites $25-$28/hr for part-time remote hospice triage. Long-term earnings growth is likely limited unless the nurse moves into triage leadership, telehealth operations, or broader hospice/home health roles.
5y outlook: Likely stable part-time/hourly remote nursing pay, with growth tied to RPM, telehealth, and care-management expansion. Progression may require moving into full-time care management, informatics, or clinical operations roles.
Centene Corporation
5y outlook: Stable mid-level payer contracting outlook with progression toward senior negotiation, network management, or managed care leadership; compensation can grow with health-system and value-based contracting experience.
5y outlook: Senior product management in healthcare technology and partnerships generally offers strong salary growth, but compensation depends on location, prior product/partnership experience, and company band. Clinicians without product experience should expect to enter below this senior level.
Vector Outsourcing Solutions Phils. Inc.
5y outlook: Experienced coders can move toward CDI, coding audit/QA, or compliance roles with better pay; however, routine chart-to-code work faces rising automation pressure, so upskilling into auditing, CDI or specialty coding is important for long-term salary growth. Exact figures vary by employer and specialty.
5y outlook: Likely stable but modest clerical/legal-support compensation with limited upside unless the person moves into case management, legal operations, or broader healthcare documentation roles. Clinicians should not expect this to replace clinical income without significant progression.
MedReview Inc.
5y outlook: Senior physician reviewer roles typically command competitive physician non-clinical compensation, though exact pay varies by specialty, licensure, payer mix, and location. Demand should remain stable as payers and review organizations manage Medicare Advantage, risk adjustment, and payment integrity.
Volga Partners
5y outlook: Pay is not disclosed, and these AI-evaluation/SME roles often function as project-based supplemental income rather than a standalone clinical salary. Over 3-5 years, experience could support transitions into healthcare AI, clinical informatics, or model-quality roles, but income will depend on contract volume and rates.